Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugs
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugs
Authors
Keywords
-
Journal
DALTON TRANSACTIONS
Volume 41, Issue 27, Pages 8226
Publisher
Royal Society of Chemistry (RSC)
Online
2012-05-01
DOI
10.1039/c2dt30075c
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Better Platinum-Based Anticancer Drug Yet to Come?
- (2012) Ulrike Olszewski et al. Anti-Cancer Agents in Medicinal Chemistry
- Catalytic metallodrugs targeting HCV IRES RNA
- (2012) Seth Bradford et al. CHEMICAL COMMUNICATIONS
- Zinc(ii) complexes of constrained antiviral macrocycles
- (2012) Allison Ross et al. DALTON TRANSACTIONS
- Cancer genetics: Evolution after tumour spread
- (2012) Steven C. Clifford NATURE
- Clonal selection drives genetic divergence of metastatic medulloblastoma
- (2012) Xiaochong Wu et al. NATURE
- From Conventional to Unusual Enzyme Inhibitor Scaffolds: The Quest for Target Specificity
- (2011) Eric Meggers ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Molecular Predictors of Response to Antiangiogenesis Therapies
- (2011) Armin Gerger et al. CANCER JOURNAL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- How do real tumors become resistant to cisplatin?
- (2011) Piet Borst et al. CELL CYCLE
- Approaching tumour therapy beyond platinum drugs
- (2011) A. Bergamo et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Metal-Based Inhibition of Poly(ADP-ribose) Polymerase − The Guardian Angel of DNA
- (2011) Filipa Mendes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structurally Sophisticated Octahedral Metal Complexes as Highly Selective Protein Kinase Inhibitors
- (2011) Li Feng et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling
- (2011) W van Veelen et al. ONCOGENE
- Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin
- (2010) Chi-Hui Tang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death
- (2010) L. Galluzzi et al. CANCER RESEARCH
- Downregulation of Bcl-x L and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy
- (2010) Emilie Varin et al. CARCINOGENESIS
- Novel Metals and Metal Complexes as Platforms for Cancer Therapy
- (2010) Michael Frezza et al. CURRENT PHARMACEUTICAL DESIGN
- Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives
- (2010) Maribel Navarro et al. DRUG DISCOVERY TODAY
- Cancer stemness and metastasis: Therapeutic consequences and perspectives
- (2010) Joana Monteiro et al. EUROPEAN JOURNAL OF CANCER
- HER2 as a target for breast cancer therapy
- (2010) Elda Tagliabue et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Towards global consensus in the treatment of gastrointestinal stromal tumor
- (2010) Peter Reichardt et al. Expert Review of Anticancer Therapy
- Recent advances in the discovery of small molecule mTOR inhibitors
- (2010) Abhijit Roychowdhury et al. Future Medicinal Chemistry
- An Iron-Based Cytosolic Catalase and Superoxide Dismutase Mimic Complex
- (2010) Adolfo Horn et al. INORGANIC CHEMISTRY
- TP53Mutations and Pathologic Complete Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity Squamous Cell Carcinoma
- (2010) Federica Perrone et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
- (2010) Daniel P. Silver et al. JOURNAL OF CLINICAL ONCOLOGY
- KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- The new platinum(IV) derivative LA-12 shows stronger inhibitory effect on Hsp90 function compared to cisplatin
- (2010) Veronika Kvardova et al. Molecular Cancer
- Hsp90: A Drug Target?
- (2010) Jeffrey M. Holzbeierlein et al. Current Oncology Reports
- Targeted Cancer Therapeutics
- (2009) William N. Hait CANCER RESEARCH
- Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
- (2009) Di Chen et al. CURRENT PHARMACEUTICAL DESIGN
- Cisplatin Versus Carboplatin in NSCLC: Is There One “Best” Answer?
- (2009) Rachel E. Sanborn CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting
- (2009) Katherine S. Lovejoy et al. DALTON TRANSACTIONS
- Satraplatin for the therapy of castration-resistant prostate cancer
- (2009) Guru Sonpavde et al. Future Oncology
- Gene signatures of pulmonary metastases of renal cell carcinoma reflect the disease-free interval and the number of metastases per patient
- (2009) Daniela Wuttig et al. INTERNATIONAL JOURNAL OF CANCER
- In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model
- (2009) A. Bergamo et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Inhibition of transcription by platinum antitumor compounds
- (2009) Ryan C. Todd et al. Metallomics
- Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells
- (2009) K. Simonin et al. MOLECULAR CANCER THERAPEUTICS
- Mechanisms of Hedgehog pathway activation in cancer and implications for therapy
- (2009) Suzie J. Scales et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
- (2008) Christian G. Hartinger et al. CHEMISTRY & BIODIVERSITY
- New pharmacological strategies against metastatic spread
- (2008) G.Y. Perret et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now